Overview
INSP market data
Price History
INSP price chart
Valuation & Profitability
- P/E (TTM)
- 12.36 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $4.89 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.74 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 15.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $38.91 – $147.03 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.7B · P/B 3.43 · P/S 1.86.
Company News
JP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60Benzinga · Aug 4, 2026, 6:39 PM
Mizuho Maintains Outperform on Inspire Medical Systems, Raises Price Target to $65Benzinga · Aug 4, 2026, 6:15 PM
Oppenheimer Upgrades Inspire Medical Systems to Outperform, Announces $85 Price TargetBenzinga · Aug 4, 2026, 5:10 PM
Truist Securities Reiterates Hold on Inspire Medical Systems, Raises Price Target to $62Benzinga · Aug 4, 2026, 4:40 PM
Caterpillar, Wayfair, Zebra Technologies, Gartner And Other Big Stocks Moving Higher On TuesdayBenzinga · Aug 4, 2026, 2:00 PM
Evercore ISI Group Maintains In-Line on Inspire Medical Systems, Raises Price Target to $54Benzinga · Aug 4, 2026, 1:22 PM
Inspire Medical Systems shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance. Baird and Piper Sandler raised their respective price targets on the stock.Benzinga · Aug 4, 2026, 12:44 PM
Inspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 ResultsBenzinga · Aug 4, 2026, 12:14 PM
Piper Sandler Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60Benzinga · Aug 4, 2026, 12:08 PM
Baird Maintains Neutral on Inspire Medical Systems, Raises Price Target to $59Benzinga · Aug 4, 2026, 10:27 AM